Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 126

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 126
---
 rates during 2025.

Interest Expense

Interest expense was $1,193 for the three months ended September 30, 2025, compared to $107,382 for the three months ended September 30, 2024, representing a decrease of $106,189, or 99%. The significant decrease in the current period reflects the repayment or conversion in prior periods of these interest-bearing obligations.

Gain on Change in Fair Value of Derivative Liability

There were no derivative liabilities in the three months ended September 30, 2025. In the prior year quarter, the Company recognized a $9,885 gain from marking to market the variable conversion features embedded in its then-outstanding convertible notes.

| 70 |

Nine months ended September 30, 2025 Compared to the Nine months ended September 30, 2024

The period-to-period comparisons of our historical results are not necessarily indicative of the results that may be expected in the future. The results of operations data for the nine months ended September 30, 2025 and September 30, 2024 have been derived from the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.

|                                                             |     | For the Nine Months Ended | September 30,  2025 |   |     |   | September 30,  2024 |   |     | Variance | September 30,  2025 |   |     |     | September 30,  2024 |   |
|:------------------------------------------------------------|:----|:--------------------------|--------------------:|:--|:----|:--|--------------------:|:--|:----|:---------|--------------------:|:--|:----|:----|--------------------:|:--|
| Expenses:                                                   |     |                           |                     |   |     |   |                     |   |     |          |                     |   |     |     |                     |   |
| Research and development                                    |     | $                         |           2,042,890 |   |     | $ |             291,655 |   |     | $        |           1,751,235 |   |     |     |                 600 | % |
| General and administrative                                  |     |                           |           4,057,046 |   |     |   |           1,341,271 |   |     |          |           2,715,775 |   |     |     |